top of page

Toxins and CRISPR

Join us in understanding how bacteria invade and manipulate hosts.

Our Focus

01

Development of CRISPR
screening technologies

02

Bacterial toxins and

other virulence factors

03

Bacteria-nematode

interactions

Screenshot 2025-11-10 at 13.51_edited.jp
20181101Experiment_001_WT6_z0_ch00_edite
20241218_155032_edited.png

Using existing and developing novel CRISPR-based screening approaches to understand how bacteria invade hosts and cause disease

Elucidating mechanisms of bacterial toxin and virulence factor interactions with and within host cells

Understanding how certain bacteria colonize nematode guts and, in some cases, kill them

We let our curiosity guide us to better understand nature, while striving to make a positive impact on society

Our Team

Our Papers

  • Hart, S. K., Müller, S., Wessels, H. H., Méndez-Mancilla, A., Drabavicius, G., Choi, O., & Sanjana, N. E. (2025). Precise RNA targeting with CRISPR–Cas13d. Nature Biotechnology, 1-6.

  • Drabavicius, G. & D. Daelemans (2021). Intermedilysin cytolytic activity depends on heparan sulfates and membrane composition PLoS genetics, 17(2), e1009387.

  • Wilkinson, M., Drabavicius, G., Silanskas, A., Gasiunas, G., Siksnys, V., & Wigley, D. B. (2019). Structure of the DNA-bound spacer capture complex of a type II CRISPR-Cas system. Molecular cell, 75(1), 90-101.

  • Drabavicius, G., Sinkunas, T., Silanskas, A., Gasiunas, G., Venclovas, Č., & Siksnys, V. (2018). DnaQ exonuclease‐like domain of Cas2 promotes spacer integration in a type I‐E CRISPR‐Cas system. EMBO reports 19(7), e45543

The Drab Lab papers

Working on it

Pre-Drab Lab papers

Contact Us

Address

Medical Sciences Center

Žaliųjų ežerų g. 2

LT - 08422, Vilnius, Lithuania

Contact

+370-617-15238

 

© 2025 by Gediminas Drabavicius 

 

bottom of page